KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arbutus Biopharma (ABUS) Depreciation & Amortization - Total: 2009-2020

Historic Depreciation & Amortization - Total for Arbutus Biopharma (ABUS) over the last 12 years, with Dec 2020 value amounting to $2.0 million.

  • Arbutus Biopharma's Depreciation & Amortization - Total fell 8.78% to $447,000 in Q3 2021 from the same period last year, while for Sep 2021 it was $1.8 million, marking a year-over-year decrease of 9.26%. This contributed to the annual value of $2.0 million for FY2020, which is 2.47% down from last year.
  • According to the latest figures from FY2020, Arbutus Biopharma's Depreciation & Amortization - Total is $2.0 million, which was down 2.47% from $2.0 million recorded in FY2019.
  • Over the past 5 years, Arbutus Biopharma's Depreciation & Amortization - Total peaked at $2.2 million during FY2018, and registered a low of $1.1 million during FY2016.
  • Over the past 3 years, Arbutus Biopharma's median Depreciation & Amortization - Total value was $2.0 million (recorded in 2019), while the average stood at $2.1 million.
  • Its Depreciation & Amortization - Total has fluctuated over the past 5 years, first spiked by 85.62% in 2017, then dropped by 7.02% in 2019.
  • Yearly analysis of 5 years shows Arbutus Biopharma's Depreciation & Amortization - Total stood at $1.1 million in 2016, then skyrocketed by 85.62% to $2.0 million in 2017, then rose by 7.60% to $2.2 million in 2018, then decreased by 7.02% to $2.0 million in 2019, then fell by 2.47% to $2.0 million in 2020.